Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing v3.5.3. This indicates an updated version of the study record history interface.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer/site revision has been updated from v3.5.2 to v3.5.3, indicating a ClinicalTrials.gov interface/platform version update rather than a change to the study record itself.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision history shows Revision: v3.5.2 added and Revision: v3.5.0 removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed. This reflects an update to the revision log rather than changes to study data or user-facing content.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.3 was added to the history, and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision: v3.4.2 was added and older notices (Revision: v3.4.1 and a government funding status notice) were removed, indicating a UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.